Production (Stage)
Fresenius Medical Care AG
FMS
$29.02
$0.48711.71%
NYSE
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 665.95M | 583.85M | 714.85M | 572.46M | 523.94M |
| Total Depreciation and Amortization | 1.45B | 1.47B | 1.48B | 1.50B | 1.63B |
| Total Amortization of Deferred Charges | 56.17M | 56.17M | 60.81M | 60.81M | 60.81M |
| Total Other Non-Cash Items | -93.66M | -11.33M | -170.27M | -71.69M | 96.44M |
| Change in Net Operating Assets | 536.07M | 484.40M | 384.45M | 154.34M | 520.17M |
| Cash from Operations | 2.62B | 2.58B | 2.47B | 2.22B | 2.84B |
| Capital Expenditure | -763.33M | -755.30M | -768.17M | -735.26M | -732.84M |
| Sale of Property, Plant, and Equipment | 13.91M | 15.04M | 19.23M | 27.15M | 20.43M |
| Cash Acquisitions | -8.19M | -665.90K | -890.10K | 5.68M | 1.90M |
| Divestitures | 653.71M | 676.89M | 698.65M | 697.73M | 215.42M |
| Other Investing Activities | -31.67M | -31.86M | -21.54M | 9.30M | 7.36M |
| Cash from Investing | -135.58M | -95.89M | -72.72M | 4.60M | -487.72M |
| Total Debt Issued | -44.56M | 146.33M | 117.31M | -49.13M | 437.29M |
| Total Debt Repaid | -1.72B | -2.07B | -1.89B | -1.67B | -2.02B |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -375.82M | -375.82M | -375.82M | -375.82M | -357.70M |
| Other Financing Activities | -299.85M | -291.89M | -230.24M | -212.78M | -240.43M |
| Cash from Financing | -2.60B | -2.77B | -2.54B | -2.47B | -2.33B |
| Foreign Exchange rate Adjustments | 8.64M | 27.34M | -52.69M | -20.88M | -49.39M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -110.96M | -254.10M | -197.30M | -268.09M | -32.30M |